Researchers investigate the duration of the immune response to SARS-CoV-2
The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration in August 2020, is within 60 days of the onset of symptoms, according to a new Penn State-led study.
The research also reveals that the ideal convalescent plasma donor is a recovered COVID-19 patient who is older than 30 and whose illness had been severe.
Millions of individuals worldwide have recovered from COVID-19 and may be eligible for participation in convalescent plasma donor programs. Our findings enable identification of the most promising donors and suggest that these people should donate quickly before their antibodies begin to wane.
E-Mail
UNIVERSITY PARK, Pa. The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration in August 2020, is within 60 days of the onset of symptoms, according to a new Penn State-led study. The research also reveals that the ideal convalescent plasma donor is a recovered COVID-19 patient who is older than 30 and whose illness had been severe. Millions of individuals worldwide have recovered from COVID-19 and may be eligible for participation in convalescent plasma donor programs, said Vivek Kapur, professor of microbiology and infectious diseases, Penn State. Our findings enable identification of the most promising donors and suggest that these people should donate quickly before their antibodies begin to wane.
Study finds short window for donating convalescent plasma to COVID-19 patients psu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psu.edu Daily Mail and Mail on Sunday newspapers.
December 18, 2020
More than 50% of children used shared devices, and there isn’t a level playing field to access to the internet, said Siddharth Pillai of Aarambh India. This is the imperfect world that guardian data fiduciaries in the country will have to navigate, according to the provisions of the Personal Data Protection (PDP) Bill, 2019. These fiduciaries are supposed to verify the age of their users, and obtain consent from their guardian or parents if the user is a “child” anyone under 18.
How will these fiduciaries do what they do, considering this complicated and confusing mandate? Held on December 9 with the support of Facebook and Google, our discussion explored how companies, NGOs and child welfare bodies will be affected by the PDP Bill. Watch full video of the discussion: